…for the want of a nail, the shoe was lost
For the want of a shoe, the horse was lost
For the want of a horse, the rider was lost
For the want of a rider, the message was lost
For the want of a nail, the world was lostTodd Rundgren’s 1989 hit, For the Want of a Nail, details an absurd set of escalating events that culminate in the end of the world. As we look across
the increasingly complex cancer care landscape, it seems that more than a few nails are missing. The scope of lost opportunities across the breadth of care disparities, the impact of unforeseen drug shortages, and the growing unsustainability of the administrative burden cast upon physicians challenge even the most optimistic amongst us to remain so. Unfortunately, these complex systems often lack the resilience to navigate unforeseen circumstances or manage the consequences of government and payer policies, however well-intentioned. In truth, when we face seemingly insurmountable challenges, we must embrace a greater sense of humility about our ideas on how this will work.
Recent drug shortages remind us that the biggest blows come from the unforeseen threat. How can it be than in 2023, as cancer mortality plummets, that the failure of a single manufacturing facility can compromise our systems of care? No medical school student worries about supply chains, yet our ability to deliver optimal patient care relies upon a multitude of events beyond our direct control.
Our health care system didn’t evolve to serve every Immediate need, and point solutions are frequently the core drivers of why medical systems look the way that they do. The American health care system leads the world by creating innovations, and early adoption of these novel technologies can improve patient outcomes. The advantages of our care system, however, will not make its shortcomings disappear. Technology alone will not save us. The biggest disconnects in our systems of care involve handoffs, transitions, and misalignments between systems capacities, clinical resources, and patient needs.
What is the way forward? While the seemingly contradictory missions of delivering higher quality care while leveraging a rapidly growing portfolio of emerging diagnostic and therapeutic technologies to deliver care at a lower cost and in ways that improve patient care experience seems impossible, leaders in the field show us how effective care strategies, technological tools, and patient-centered care can move us toward this ideal state.
Apeirophobia is the fear of infinity. It is easy to look at the near infinite challenges that confront us as we create the future of oncology and become overwhelmed to the point of near paralysis by the enormity of the tasks that lie ahead. Yet success is never accidental, and it is rarely achieved in isolation. The best prospects for building the most resilient future possible for oncology lies in better aligning the breadth of oncology care stakeholders in ways that enhance collaboration and cross-disciplinary learning, while ensuring that the drive the reduce costs does not lead us to underinvest in what it takes to do so sustainably.
Reference
Todd Rundgren. For Want of a Nail. Nearly Human. Warner Records. May 18, 1989.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More